Global Well being Group. Reality sheet: influenza (seasonal). WHO Media Centre. http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed twentieth August 2020 (2018).
Osterholm, M. T., Kelley, N. S., Sommer, A. & Belongia, E. A. Efficacy and effectiveness of influenza vaccines: a scientific evaluate and meta-analysis. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(11)70295-X (2012).
Kwong, J. C. et al. Acute myocardial infarction after laboratory-confirmed influenza an infection. N. Engl. J. Med. 378, 345–353 (2018).
Warren-Gash, C., Blackburn, R., Whitaker, H., McMenamin, J. & Hayward, A. C. Laboratory-confirmed breathing infections as triggers for acute myocardial infarction and stroke: a self-controlled case sequence evaluation of nationwide connected datasets from Scotland. Eur. Respir. J. 51, 1701794 (2018).
Dealers, S. A., Hagan, R. S., Hayden, F. G. & Fischer, W. A. The hidden burden of influenza: a evaluate of the extra-pulmonary headaches of influenza an infection.Influenza Different Respir. Viruses 11, 372–393 (2017).
Rothman, Ok. J. & Greenland, S. Causation and causal inference in epidemiology. Am. J. Public Well being 95, 144–150 (2005).
Modin, D. et al. Influenza vaccine in center failure: cumulative collection of vaccinations, frequency, timing, and survival: a Danish National Cohort Find out about. Circulate 139, 575–586 (2019).
Udell, J. A. et al. Affiliation between influenza vaccination and cardiovascular results in high-risk sufferers: a meta-analysis. JAMA 310, 1711–1720 (2013).
DiazGranados, C. A. et al. Prevention of great occasions in adults 65 years of age or older: a comparability between high-dose and standard-dose inactivated influenza vaccines. Vaccine 33, 4988–4993 (2015).
Kendall, J. M. Designing a analysis challenge: randomised managed trials and their ideas. Emerg. Med. J. 20, 164–168 (2003).
Li, L. et al. Heterogeneity in estimates of the have an effect on of influenza on inhabitants mortality: a scientific evaluate. Am. J. Epidemiol. 187, 378–388 (2018).
DiazGranados, C. A. et al. Efficacy of high-dose as opposed to standard-dose influenza vaccine in older adults. N. Engl. J. Med. 371, 635–645 (2014).
Dunkle, L. M. et al. Efficacy of recombinant influenza vaccine in adults 50 years of age or older. N. Engl. J. Med. 376, 2427–2436 (2017).
Beran, J. et al. Prevention of influenza all the way through mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, managed, multicentre, section 3 efficacy learn about. Lancet Infect. Dis. 3099, 1–11 (2021).
Li, A. P. Y. et al. Immunogenicity of ordinary, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults. npj Vaccines 6, 1–12 (2021).
Gamerman, V., Cai, T. & Elsäßer, A. Pragmatic randomized medical trials: best possible practices and statistical steerage. Heal. Serv. Results Res. Methodol. 19, 23–35 (2019).
Hollingsworth, R. et al. Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and breathing occasions in folks elderly 65 years and above: rationale and design of a real-world pragmatic randomized medical trial. Am. Middle J. 237, 54–61 (2021).
International Influenza Surveillance and Reaction Gadget (GISRS). Flunet—influenza laboratory surveillance knowledge. WHO. https://www.who.int/equipment/flunet. Accessed 1st June 2021 (2021).
Walker, T. A. et al. Possibility of critical influenza amongst adults with continual clinical prerequisites. J. Infect. Dis. 221, 183–190 (2020).
Coleman, B. L., Fadel, S. A., Fitzpatrick, T. & Thomas, S. M. Possibility components for severe results related to influenza sickness in high- as opposed to low- and middle-income international locations: systematic literature evaluate and meta-analysis. Influenza Different Respir. Viruses 12, 22–29 (2018).
Eu Centre for Illness Prevention and Regulate. Seasonal Influenza Vaccination in Europe – Assessment of Vaccination Suggestions and Protection Charges within the EU Member States for the 2013–14 and 2014–15 Influenza Seasons. https://doi.org/10.2900/956547 (2016).
Remschmidt, C., Wichmann, O. & More difficult, T. Frequency and have an effect on of confounding through indication and wholesome vaccinee bias in observational research assessing influenza vaccine effectiveness: a scientific evaluate. BMC Infect. Dis 15, 429 (2015).
Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, Ok. M. & Weiss, N. S. Proof of bias in estimates of influenza vaccine effectiveness in seniors. Int. J. Epidemiol 35, 337–344 (2006).
Collins, R., Bowman, L., Landray, M. & Peto, R. The magic of randomization as opposed to the parable of real-world proof. N. Engl. J. Med. 382, 674–678 (2020).
Vardeny, O. et al. Impact of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in sufferers with high-risk heart problems. JAMA 325, 39 (2021).
Izurieta, H. S. et al. Comparative effectiveness of influenza vaccines amongst U.S. Medicare beneficiaries ages 65 years and older all the way through the 2019-20 season. Clin. Infect. Dis. 73, e4251–e4259 (2021).
van Aalst, R. et al. Evaluating the have an effect on of high-dose as opposed to ordinary dose influenza vaccines on hospitalization price for cardiovascular and breathing sicknesses: financial evaluate in the United States Veteran inhabitants all the way through 5 breathing seasons the use of an instrumental variable met. Vaccine 39, A51–A55 (2020).
Fröbert, O. et al. Design and rationale for the Influenza Vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized medical trial. Am. Middle J. 189, 94–102 (2017).
GOV.UK. Vaccine uptake steerage and the most recent protection knowledge. https://www.gov.united kingdom/govt/collections/vaccine-uptake. Accessed ninth March 2021 (2021).
Statens Serum Institut. Statens Serum Institute – knowledge on influenza vaccine protection. https://statistik.ssi.dk/. Accessed eleventh Might 2021 (2021).
Papanicolas, I., Mossialos, E., Gundersen, A., Woskie, L. & Jha, A. Ok. Efficiency of UK Nationwide Well being Provider when put next with different excessive revenue international locations: observational learn about. BMJ 367, 1–12 (2019).
Clar, C., Oseni, Z., Plants, N., Keshtkar-Jahromi, M. & Rees, Ok. Influenza vaccines for fighting heart problems. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD005050.pub3 (2015).
Hamilton, M. A. et al. Validating Global Classification of Illness tenth Revision algorithms for figuring out influenza and breathing syncytial virus hospitalizations. PLoS ONE 16, 1–12 (2021).
Thompson, W. W. et al. Influenza-associated hospitalizations in america. JAMA 292, 1333–1340 (2004).
Public Well being England. The Nationwide Influenza Immunisation Programme 2020 to 2021 Inactivated Influenza Vaccine Knowledge for Healthcare Practitioners (Public Well being England, 2020).
Statens Serum Institut. Influenza vaccination. https://www.ssi.dk/vaccinationer/influenzavaccination (2021).
Schmidt, M., Pedersen, L. & Sørensen, H. T. The Danish Civil Registration Gadget as a device in epidemiology. Eur. J. Epidemiol. 29, 541–549 (2021).
Schmidt, M. et al. The Danish Nationwide affected person registry: a evaluate of content material, knowledge high quality, and analysis possible. Clin. Epidemiol. 7, 449–490 (2015).
Padmanabhan, S. et al. Solution to document linkage of number one care knowledge from Scientific Apply Analysis Datalink to different health-related affected person knowledge: assessment and implications. Eur. J. Epidemiol. 34, 91–99 (2019).
Wolf, A. et al. Information useful resource profile: Scientific Apply Analysis Datalink (CPRD) Aurum. Int. J. Epidemiol. 48, 1740–1740G (2019).
Herrett, E. et al. Information useful resource profile: Scientific Apply Analysis Datalink (CPRD). Int. J. Epidemiol. 44, 827–836 (2015).
CPRD knowledge. https://cprd.com/Information. Accessed twenty ninth November 2019 (2021).
Herbert, A., Wijlaars, L., Zylbersztejn, A., Cromwell, D. & Hardelid, P. Information useful resource profile: Clinic Episode Statistics Admitted Affected person Care (HES APC). Int. J. Epidemiol. 46, 1093–1093i (2021).
Gravenstein, S. et al. Comparative effectiveness of high-dose as opposed to standard-dose influenza vaccination on numbers of US nursing house citizens admitted to sanatorium: a cluster-randomised trial. Lancet Respir. Med. 5, 738–746 (2017).
Younger-Xu, Y. et al. Research of relative effectiveness of high-dose as opposed to standard-dose influenza vaccines the use of an instrumental variable approach. Vaccine 37, 1484–1490 (2019).
Frome, E. L. & Checkoway, H. Epidemiologic techniques for computer systems and calculators. Use of Poisson regression fashions in estimating occurrence charges and ratios. Am. J. Epidemiol. 121, 309–323 (1985).
Payne, E. H. et al. Approaches for coping with more than a few resources of overdispersion in modeling depend knowledge: Scale adjustment as opposed to modeling. Stat. Strategies Med. Res. 26, 1802–1823 (2017).